explore -WSS

explore

author：entertainment 2025-09-05 13:32:18 - browse：95

Warning sign illustration made of 0s and 1s. -- first opinion coverage from sTAT — Adobe

Big businesses poised to profit from the advance of artificial intelligence in health care are pushing back against newly proposed federal rules meant to increase oversight and fairness of AI tools used to help make decisions about patient care.

The opposition, which includes Google and Amazon as well as large health care providers, insurers, and medical software vendors, is focused on an attempt to put tighter guardrails around the use of AI by the Office of the National Coordinator for Health Information Technology.

The agency wants to require developers of electronic health records and other health software to provide users with details about the training and testing of predictive models that draw data from their systems, or are hosted within them. It also wants developers to assess and publicly disclose potential risks and create a way for clinicians and other users to report problems.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： How doctors and nurses shape Google's AI

focus

Wikipedia

WSS

European regulators consider appeal over Amylyx ALS drug

European regulators consider appeal over Amylyx ALS drug

STAT Readout: Today's biotech news includes Sana and Amylyx

Health AI: on the border between health care and tech

Judge sides with young activists in first

Humana CEO Bruce Broussard to step down in 2024

hotspot

explore

leisure time

Apple is now the first public company to be valued at $3 trillion

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

Duchenne breakthrough therapy leaves behind pioneering families

Health AI: on the border between health care and tech

Jerome Adams on the need for new antivirals for Covid

Life sciences deals on track to hit lowest point since 2017

United colonoscopy coverage change 'may cost lives,' doctors say

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

State Dept. review finds Biden bears some blame for Afghanistan failures

European regulators consider appeal over Amylyx ALS drug

entertainment

What's changing in Medicare's open enrollment this year?

Takeaways from AdvaMed, the largest medical devices conference

Aspartame and sugar

Hospitals are dialing back on venture capital investing

Researchers CRISPR chickens in bid to protect them from bird flu

Hospitals are dialing back on venture capital investing

focus

focus

Wikipedia

knowledge